Assignee

PHARMACIA CORP

US187 patents

Top patents by PatentIndex Score

US6545170B2Apr 8, 2003

2-amino-5, 6 heptenoic acid derivatives useful as nitric oxide synthase inhibitors

PHARMACIA CORP97 citations98

US6979686B1Dec 27, 2005

Substituted pyrazoles as p38 kinase inhibitors

PHARMACIA CORP64 citations96

US6723752B2Apr 20, 2004

(R)-chiral halogenated substituted n-benzyl-n-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity

PHARMACIA CORP53 citations96

US6723753B2Apr 20, 2004

Substituted n-benzyl-n-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity

PHARMACIA CORP22 citations96

US6710089B2Mar 23, 2004

Substituted N-fused-phenyl-N-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity

PHARMACIA CORP23 citations96

US6683099B2Jan 27, 2004

Substituted N,N-disubstituted cycloalkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity

PHARMACIA CORP19 citations96

US6677375B2Jan 13, 2004

Substituted N,N-bis-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity

PHARMACIA CORP19 citations96

US6586474B2Jul 1, 2003

Acid-stable and cationic-compatible cellulose compositions and methods of preparation

PHARMACIA CORP52 citations94

US6110271AAug 29, 2000

Methods for improved rheological control in cementitious systems

PHARMACIA CORP136 citations94

US7183287B2Feb 27, 2007

Substituted pyrimidinones

PHARMACIA CORP50 citations93

US6677341B2Jan 13, 2004

(R)-Chiral halogenated substituted heteroaryl benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity

PHARMACIA CORP13 citations93

US6624180B2Sep 23, 2003

Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade

PHARMACIA CORP56 citations93

US6586433B2Jul 1, 2003

Substituted N-heteroaryl-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity

PHARMACIA CORP13 citations93

US6521607B1Feb 18, 2003

(R)-chiral halogenated substituted N-phenoxy N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity

PHARMACIA CORP17 citations93

US6509361B1Jan 21, 2003

1,5-Diaryl substituted pyrazoles as p38 kinase inhibitors

PHARMACIA CORP64 citations93

US7196118B2Mar 27, 2007

Amidino compounds useful as nitric oxide synthase inhibitors

PHARMACIA CORP24 citations92

US6914158B2Jul 5, 2005

Amidino compounds useful as nitric oxide synthase inhibitors

PHARMACIA CORP17 citations92

US6906078B2Jun 14, 2005

Method of using (H+/K+) ATPase inhibitors as antiviral agents

PHARMACIA CORP23 citations92

US6852753B2Feb 8, 2005

Alkyl/aryl hydroxy or keto thiepine compounds as inhibitors of apical sodium co-dependent bile acid transport (ASBT) and taurocholate uptake

PHARMACIA CORP41 citations92

US6750228B1Jun 15, 2004

Aromatic sulfone hydroxamic acid metalloprotease inhibitor

PHARMACIA CORP35 citations92

US6683093B2Jan 27, 2004

Aromatic sulfone hydroxamic acids and their use as protease inhibitors

PHARMACIA CORP27 citations92

US6673818B2Jan 6, 2004

Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation

PHARMACIA CORP19 citations92

US6660885B2Dec 9, 2003

Polycyclic aryl and heteroaryl substituted benzenes useful for selective inhibition of the coagulation cascade

PHARMACIA CORP20 citations92

US6635282B1Oct 21, 2003

Gellan gum tablet film coating

PHARMACIA CORP13 citations92

US6613790B2Sep 2, 2003

Prodrugs of COX-2 inhibitors

PHARMACIA CORP17 citations92

US6579873B2Jun 17, 2003

3 (5)-heteroaryl substituted pyrazoles as p38 kinase inhibitors

PHARMACIA CORP14 citations92

US6525041B1Feb 25, 2003

Manganese or iron complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide

PHARMACIA CORP51 citations92

US6495544B2Dec 17, 2002

Homoiminopiperidinyl hexanoic acid inhibitors of inducible nitric oxide synthase

PHARMACIA CORP38 citations92

US6451833B1Sep 17, 2002

N-substituted (α-imidazolyl-toluyl)pyrrole compounds for treatment of circulatory disorders

PHARMACIA CORP19 citations92

US6436967B1Aug 20, 2002

Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors

PHARMACIA CORP27 citations92

US6432999B2Aug 13, 2002

Pyrazole substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors

PHARMACIA CORP35 citations92

US7445641B1Nov 4, 2008

Biomaterials modified with superoxide dismutase mimics

PHARMACIA CORP44 citations90

US7067540B2Jun 27, 2006

Substituted pyridinones

PHARMACIA CORP44 citations90

US7005450B2Feb 28, 2006

2-amino-2-alkyl-4 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors

PHARMACIA CORP18 citations90

US6605624B1Aug 12, 2003

Substituted pyridines useful for inhibiting cholesteryl ester transfer protein activity

PHARMACIA CORP23 citations90

US6385589B1May 7, 2002

System for monitoring and managing the health care of a patient population

PHARMACIA CORP403 citations90

US6814966B1Nov 9, 2004

Methods for treating glaucoma

PHARMACIA CORP37 citations89

US6579895B2Jun 17, 2003

Use of a celecoxib composition for fast pain relief

PHARMACIA CORP46 citations89

US6531128B1Mar 11, 2003

Methods for treating glaucoma

PHARMACIA CORP36 citations89

US6106603AAug 22, 2000

Stable suspension of hydrocolloids and superplasticizer

PHARMACIA CORP21 citations89

US6660257B1Dec 9, 2003

Circular permuteins of flt3 ligand

PHARMACIA CORP26 citations88

US7012098B2Mar 14, 2006

Inhibitors of inducible nitric oxide synthase for chemoprevention and treatment of cancers

PHARMACIA CORP29 citations87

US6964978B2Nov 15, 2005

Solid-state form of celecoxib having enhanced bioavailability

PHARMACIA CORP22 citations87

US6747020B2Jun 8, 2004

Methods of treating heart failure and hypertension using combinations of eplerenone and an angiotensin converting enzyme inhibitor

PHARMACIA CORP18 citations87

US7259266B2Aug 21, 2007

Benzopyran compounds useful for treating inflammatory conditions

PHARMACIA CORP38 citations86

US6696426B2Feb 24, 2004

Preservative free ophthalmic oxazolidinone antibiotic drug delivery systems

PHARMACIA CORP43 citations86

Showing the top 50 of 187 patents by PatentIndex Score.

PHARMACIA CORP

Top patents by PatentIndex Score

2-amino-5, 6 heptenoic acid derivatives useful as nitric oxide synthase inhibitors

Substituted pyrazoles as p38 kinase inhibitors

(R)-chiral halogenated substituted n-benzyl-n-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity

Substituted n-benzyl-n-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity

Substituted N-fused-phenyl-N-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity

Substituted N,N-disubstituted cycloalkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity

Substituted N,N-bis-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity

Amidino compounds useful as nitric oxide synthase inhibitors

Amidino compound and salts thereof useful as nitric oxide synthase inhibitors

Gellan gum tablet coating

Method of changing conformation of a matrix metalloproteinase

Acid-stable and cationic-compatible cellulose compositions and methods of preparation

Methods for improved rheological control in cementitious systems

Substituted pyrimidinones

(R)-Chiral halogenated substituted heteroaryl benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity

Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade

Substituted N-heteroaryl-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity

(R)-chiral halogenated substituted N-phenoxy N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity

1,5-Diaryl substituted pyrazoles as p38 kinase inhibitors

Amidino compounds useful as nitric oxide synthase inhibitors

Amidino compounds useful as nitric oxide synthase inhibitors

Method of using (H+/K+) ATPase inhibitors as antiviral agents

Alkyl/aryl hydroxy or keto thiepine compounds as inhibitors of apical sodium co-dependent bile acid transport (ASBT) and taurocholate uptake

Aromatic sulfone hydroxamic acid metalloprotease inhibitor

Aromatic sulfone hydroxamic acids and their use as protease inhibitors

Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation

Polycyclic aryl and heteroaryl substituted benzenes useful for selective inhibition of the coagulation cascade

Gellan gum tablet film coating

Prodrugs of COX-2 inhibitors

3 (5)-heteroaryl substituted pyrazoles as p38 kinase inhibitors

Manganese or iron complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide

Homoiminopiperidinyl hexanoic acid inhibitors of inducible nitric oxide synthase

N-substituted (α-imidazolyl-toluyl)pyrrole compounds for treatment of circulatory disorders

Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors

Pyrazole substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors

Biomaterials modified with superoxide dismutase mimics

Substituted pyridinones

2-amino-2-alkyl-4 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors

Substituted pyridines useful for inhibiting cholesteryl ester transfer protein activity

System for monitoring and managing the health care of a patient population

Methods for treating glaucoma

Use of a celecoxib composition for fast pain relief

Methods for treating glaucoma

Stable suspension of hydrocolloids and superplasticizer

Circular permuteins of flt3 ligand

Inhibitors of inducible nitric oxide synthase for chemoprevention and treatment of cancers

Solid-state form of celecoxib having enhanced bioavailability

Methods of treating heart failure and hypertension using combinations of eplerenone and an angiotensin converting enzyme inhibitor

Benzopyran compounds useful for treating inflammatory conditions

Preservative free ophthalmic oxazolidinone antibiotic drug delivery systems